Parasitic helminths: New weapons against immunological disorders

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Osada, Yoshio ^a   Kanazawa, Tamotsu ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HELMINTH PROTEIN; OLIGOSACCHARIDE; PARASITE ANTIGEN;

AUTOIMMUNITY; HELMINTH; HELMINTHIASIS; HUMAN; HYGIENE HYPOTHESIS; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOTHERAPY; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; SCHISTOSOMA MANSONI; TH17 CELL; WORM EGG; ANIMAL; ARTHRITIS; AUTOIMMUNE DISEASE; HELPER CELL; IMMUNOLOGY; PARASITE;

SCHISTOSOMA MANSONI; VERMES;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; HELMINTHS; HUMANS; IMMUNE SYSTEM DISEASES; PARASITES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77954611380     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/743758     Document Type: Review

References (104)

1. D. P. Strachan, "Hay fever, hygiene, and household size," British Medical Journal, vol. 299, no. 6710, pp. 1259-1260, 1989. (Pubitemid 19280051)
2. J. F. Kurtzke, "Multiple sclerosis in time and space-geographic clues to cause," Journal of NeuroVirology, vol. 6, supplement 2, pp. S134-S140, 2000. (Pubitemid 30348927)
3. D. E. Elliott, R. W. Summers, and J. V. Weinstock, "Helminths as governors of immune-mediated inflammation," International Journal for Parasitology, vol. 37, no. 5, pp. 457-464, 2007. (Pubitemid 46399709)
4. P. Zaccone, Z. Fehervari, J. M. Phillips, D. W. Dunne, and A. Cooke, "Parasitic worms and inflammatory diseases," Parasite Immunology, vol. 28, no. 10, pp. 515-523, 2006. (Pubitemid 44370857)
5. C. Green, L. Elliott, C. Beaudoin, and C. N. Bernstein, "A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues," American Journal of Epidemiology, vol. 164, no. 7, pp. 615-623, 2006. (Pubitemid 44453488)
6. H. Aoyama, T. Hirata, H. Sakugawa, et al., "An inverse relationship between autoimmune liver diseases and strongy-loides stercoralis infection," American Journal of Tropical Medicine and Hygiene, vol. 76, no. 5, pp. 972-976, 2007. (Pubitemid 351627689)
7. C. Flohr, R. J. Quinnell, and J. Britton, "Do helminth parasites protect against atopy and allergic disease?" Clinical & Experimental Allergy, vol. 39, no. 1, pp. 20-32, 2009.
8. D. M. McKay, "The therapeutic helminth?" Trends in Para-sitology, vol. 25, no. 3, pp. 109-114, 2009.
9. P. Zaccone, O. T. Burton, and A. Cooke, "Interplay of parasite-driven immune responses and autoimmunity," Trends in Parasitology, vol. 24, no. 1, pp. 35-42, 2008.
10. K. J. Erb, "Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases?" Tr e n d s in Immunology, vol. 30, no. 2, pp. 75-82, 2009.
11. H. Park, Z. Li, X. O. Yang, et al., "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17," Nature Immunology, vol. 6, no. 11, pp. 1133-1141, 2005. (Pubitemid 41541791)
12. T. Aranami and T. Yamamura, "Th17 cells and autoimmune encephalomyelitis (EAE/MS)," Allergology International, vol. 57, no. 2, pp. 115-120, 2008. (Pubitemid 351897665)
13. Y. Komiyama, S. Nakae, T. Matsuki, et al., "IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis," Journal of Immunology, vol. 177, no. 1, pp. 566-573, 2006. (Pubitemid 43939170)
14. H. Toyoda and B. Formby, "Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model," BioEssays, vol. 20, no. 9, pp. 750-757, 1998. (Pubitemid 28485902)
15. J. Cantor and K. Haskins, "Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-α," Journal of Immunology, vol. 175, no. 11, pp. 7738-7745, 2005. (Pubitemid 41713474)
16. J.-T. Hung, J.-H. Liao, Y.-C. Lin, et al., "Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model," Journal of Autoimmunity, vol. 25, no. 3, pp. 181-192, 2005. (Pubitemid 41654462)
17. D. Bending, H. De La Peña, M. Veldhoen, et al., "Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice," Journal of Clinical Investigation, vol. 119, no. 3, pp. 565-572, 2009.
18. N. Martin-Orozco, Y. Chung, S. H. Chang, Y.-H. Wang, and C. Dong, "Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells," European Journal of Immunology, vol. 39, no. 1, pp. 216-224, 2009.
19. L. Camoglio, A. A. te Velde, A. de Boer, F. J. ten Kate, M. Kopf, and S. J. van Deventer, "Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-γ receptor-deficient mice," European Journal of Immunology, vol. 30, no. 5, pp. 1486-1495, 2000. (Pubitemid 30311980)
20. K. Tozawa, H. Hanai, K. Sugimoto, et al., "Evidence for the critical role of interleukin-12 but not interferon-γ in the pathogenesis of experimental colitis in mice," Journal of Gastroenterology and Hepatology, vol. 18, no. 5, pp. 578-587, 2003. (Pubitemid 36645293)
21. T. Dohi, K. Fujihashi, H. Kiyono, C. O. Elson, and J. R. McGhee, "Mice deficient in Th1-and Th2-type cytokines develop distinct forms of hapten-induced colitis," Gastroen-terology, vol. 119, no. 3, pp. 724-733, 2000.
22. Z. Zhang, M. Zheng, J. Bindas, P. Schwarzenberger, and J. K. Kolls, "Critical role of IL-17 receptor signaling in acute TNBS-induced colitis," Inflammatory Bowel Diseases, vol. 12, no. 5, pp. 382-388, 2006.
23. W. O'Connor Jr., M. Kamanaka, C. J. Booth, et al., "A protective function for interleukin 17A in T cell-mediated intestinal inflammation," Nature Immunology, vol. 10, no. 6, pp. 603-609, 2009.
24. A. C. La Flamme, K. Ruddenklau, and B. T. Bäckström, "Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis," Infection and Immunity, vol. 71, no. 9, pp. 4996-5004, 2003. (Pubitemid 37070742)
25. D. Sewell, Z. Qing, E. Reinke, et al., "Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization," International Immunology, vol. 15, no. 1, pp. 59-69, 2003. (Pubitemid 36163769)
26. X. Zheng, X. Hu, G. Zhou, et al., "Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response," Journal of Neuroimmunology, vol. 194, no. 1-2, pp. 107-114, 2008.
27. A. Gruden-Movsesijan, N. Ilic, M. Mostarica-Stojkovic, S. Stosic-Grujicic, M. Milic, and Lj. Sofronic-Milosavljevic, "Trichinella spiralis: modulation of experimental autoimmune encephalomyelitis in DA rats," Experimental Parasitol-ogy, vol. 118, no. 4, pp. 641-647, 2008.
28. N. E. Ruyssers, B. Y. De Winter, J. G. De Man, et al., "Therapeutic potential of helminth soluble proteins in TNBS induced colitis in mice," Inflammatory Bowel Diseases, vol. 15, no. 4, pp. 491-500, 2009.
29. D. E. Elliott, J. Li, A. Blum, et al., "Exposure to schistosome eggs protects mice from TNBS-induced colitis," American Journal of Physiology, vol. 284, no. 3, pp. G385-G391, 2003. (Pubitemid 36227886)
30. T. G. Moreels, R. J. Nieuwendijk, J. G. De Man, et al., "Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trini-trobenzene sulphonic acid induced colitis in rats," Gut, vol. 53, no. 1, pp. 99-107, 2004. (Pubitemid 38083017)
31. + Tregs and prevent development of colitis in mice," Experimental Parasitology, vol. 116, no. 4, pp. 385-389, 2007.
32. P. Zaccone, O. Burton, N. Miller, F. M. Jones, D. W. Dunne, and A. Cooke, "Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice," European Journal of Immunology, vol. 39, no. 4, pp. 1098-1107, 2009.
33. N. E. Mangan, N. van Rooijen, A. N. J. McKenzie, and P. G. Fallon, "Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperrespon-siveness," Journal of Immunology, vol. 176, no. 1, pp. 138-147, 2006. (Pubitemid 43023257)
34. N. E. Mangan, R. E. Fallon, P. Smith, N. van Rooijen, A. N. McKenzie, and P. G. Fallon, "Helminth infection protects mice from anaphylaxis via IL-10-producing B cells," Journal of Immunology, vol. 173, no. 10, pp. 6346-6356, 2004. (Pubitemid 39487794)
35. + T cells and modulate airway inflammation in a murine model of asthma," Immunology, vol. 120, no. 1, pp. 8-18, 2006. (Pubitemid 44950465)
36. M. S. Wilson, M. D. Taylor, A. Balic, C. A. M. Finney, J. R. Lamb, and R. M. Maizels, "Suppression of allergic airway inflammation by helminth-induced regulatory T cells," Journal of Experimental Medicine, vol. 202, no. 9, pp. 1199-1212, 2005. (Pubitemid 41586951)
37. F. A. C. Rocha, A. K. R. M. Leite, M. M. L. Pompeu, et al., "Protective effect of an extract from Ascaris suum in experimental arthritis models," Infection and Immunity, vol. 76, no. 6, pp. 2736-2745, 2008.
38. D. M. Itami, T. M. Oshiro, C. A. Araujo, et al., "Modulation of murine experimental asthma by Ascaris suum components," Clinical & Experimental Allergy, vol. 35, no. 7, pp. 873-879, 2005. (Pubitemid 41032534)
39. + regulatory T cells," Immunology, vol. 127, no. 4, pp. 512-522, 2009.
40. Q. Liu, K. Sundar, P. K. Mishra, et al., "Helminth infection can reduce insulitis and type 1 diabetes through CD25-and IL-10-independent mechanisms," Infection and Immunity, vol. 77, no. 12, pp. 5347-5358, 2009.
41. M. M. Hunter, A. Wang, C. L. Hirota, and D. M. McKay, "Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis," Journal of Immunology, vol. 174, no. 11, pp. 7368-7375, 2005. (Pubitemid 40705707)
42. C. Lima, A. Perini, M. L. B. Garcia, M. A. Martins, M. M. Teixeira, and M. S. Macedo, "Eosinophilic inflammation and airway hyper-responsiveness are profoundly inhibited by a helminth (Ascaris suum) extract in a murine model of asthma," Clinical & Experimental Allergy, vol. 32, no. 11, pp. 1659-1666, 2002. (Pubitemid 35370544)
43. A. M. Dittrich, A. Erbacher, S. Specht, et al., "Helminth infection with Litomosoides sigmodontis induces regulatory T cells and inhibits allergic sensitization, airway inflammation, and hyperreactivity in a murine asthma model," Journal of Immunology, vol. 180, no. 3, pp. 1792-1799, 2008.
44. A. Melon, A. Wang, V. Phan, and D. M. McKay, "Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically-induced colitis in mice," Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 384523, 7 pages, 2010.
45. A. Espinoza-Jiménez, I. Rivera-Montoya, R. Cardenas-Arreola, L. Morán, and L. I. Terrazas, "Taenia crassiceps Infection attenuates multiple low-dose streptozotocin-induced diabetes," Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 850541, 11 pages, 2010.
46. S. Romagnani, "Regulation of the T cell response," Clinical & Experimental Allergy, vol. 36, no. 11, pp. 1357-1366, 2006. (Pubitemid 44674119)
47. Y. Osada, S. Shimizu, T. Kumagai, S. Yamada, and T. Kanazawa, "Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators," International Journal for Parasitol-ogy, vol. 39, no. 4, pp. 457-464, 2009.
48. D. E. Elliott, A. Metwali, J. Leung, et al., "Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production," Journal of Immunology, vol. 181, no. 4, pp. 2414-2419, 2008.
49. K. P. Walsh, M. T. Brady, C. M. Finlay, L. Boon, and K. H. Mills, "Infection with a helminth parasite attenuates autoim-munity through TGF-β-mediated suppression of Th17 and Th1 responses," Journal of Immunology, vol. 183, no. 3, pp. 1577-1586, 2009.
50. + cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development," Journal of Immunology, vol. 173, no. 2, pp. 1224-1231, 2004. (Pubitemid 38924300)
51. A. H. J. van den Biggelaar, R. van Ree, L. C. Rodrigues, et al., "Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10," The Lancet, vol. 356, no. 9243, pp. 1723-1727, 2000.
52. M. Medeiros Jr., J. P. Figueiredo, M. C. Almeida, et al., "Schis-tosoma mansoni infection is associated with a reduced course of asthma," Journal of Allergy and Clinical Immunology, vol. 111, no. 5, pp. 947-951, 2003. (Pubitemid 36570852)
53. C. Flohr, L. N. Tuyen, R. J. Quinnell, et al., "Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam," Clinical & Experimental Allergy, vol. 40, no. 1, pp. 131-142, 2010.
54. E. Pinelli, C. Withagen, M. Fonville, et al., "Persistent airway hyper-responsiveness and inflammation in Toxocara canis-infected BALB/c mice," Clinical & Experimental Allergy, vol. 35, no. 6, pp. 826-832, 2005. (Pubitemid 40961358)
55. E. Pinelli, S. Brandes, J. Dormans, E. Gremmer, and H. van Loveren, "Infection with the roundworm To x o c a r a canis leads to exacerbation of experimental allergic airway inflammation," Clinical & Experimental Allergy, vol. 38, no. 4, pp. 649-658, 2008. (Pubitemid 351406060)
56. P. G. Fallon and N. E. Mangan, "Suppression of TH2-type allergic reactions by helminth infection," Nature Reviews Immunology, vol. 7, no. 3, pp. 220-230, 2007.
57. + cells," Diagnostic Microbiology and Infectious Disease, vol. 62, no. 3, pp. 280-286, 2008.
58. L. W. Collison, C. J. Workman, T. T. Kuo, et al., "The inhibitory cytokine IL-35 contributes to regulatory T-cell function," Nature, vol. 450, no. 7169, pp. 566-569, 2007. (Pubitemid 350190247)
59. A. J. Melendez, M. M. Harnett, P. N. Pushparaj, et al., "Inhibition of FcεRI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes," Nature Medicine, vol. 13, no. 11, pp. 1375-1381, 2007. (Pubitemid 350073593)
60. M. Rodróguez-Sosa, A. R. Satoskar, R. Calderón, et al., "Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability," Infection and Immunity, vol. 70, no. 7, pp. 3656-3664, 2002.
61. D. R. Herbert, C. Hölscher, M. Mohrs, et al., "Alternative macrophage activation is essential for survival during schis-tosomiasis and downmodulates T helper 1 responses and immunopathology," Immunity, vol. 20, no. 5, pp. 623-635, 2004. (Pubitemid 38659504)
62. H2 cells induce alternatively activated macrophages to mediate protection against nematode parasites," Nature Medicine, vol. 12, no. 8, pp. 955-960, 2006. (Pubitemid 44175149)
63. F. O. Martinez, L. Helming, and S. Gordon, "Alternative activation of macrophages: an immunologic functional perspective," Annual Review of Immunology, vol. 27, pp. 451-483, 2009.
64. P. Smith, N. E. Mangan, C. M. Walsh, et al., "Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism," Journal of Immunology, vol. 178, no. 7, pp. 4557-4566, 2007. (Pubitemid 46492408)
65. J. M. Stuart, A. S. Townes, and A. H. Kang, "Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice," Journal of Clinical Investigation, vol. 69, no. 3, pp. 673-683, 1982. (Pubitemid 12184965)
66. L. A. B. Joosten, E. Lubberts, M. M. A. Helsen, and W. B. van den Berg, "Dual role of IL-12 in early and late stages of murine collagen type II arthritis," Journal of Immunology, vol. 159, no. 8, pp. 4094-4102, 1997. (Pubitemid 127469668)
67. E. F. Rosloniec, K. Latham, and Y. B. Guedez, "Paradoxical roles of IFN-γ in models in Th1-mediated autoimmunity," Arthritis Research, vol. 4, no. 6, pp. 333-336, 2002. (Pubitemid 35364001)
68. + myelopoiesis," Arthritis Research & Therapy, vol. 6, no. 3, pp. R220-R231, 2004.
69. + regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma," Arthritis Research & Therapy, vol. 7, no. 2, pp. R402-R415, 2005.
70. I. M. Irmler, M. Gajda, and R. Bräuer, "Exacerbation of antigen-induced arthritis in IFN-γ-deficient mice as a result of unrestricted IL-17 response," Journal of Immunology, vol. 179, no. 9, pp. 6228-6236, 2007.
71. C.-Q. Chu, D. Swart, D. Alcorn, J. Tocker, and K. B. Elkon, "Interferon-γ regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17," Arthritis & Rheumatism, vol. 56, no. 4, pp. 1145-1151, 2007. (Pubitemid 46608639)
72. C. A. Murphy, C. L. Langrish, Y. Chen, et al., "Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation," Journal of Experimental Medicine, vol. 198, no. 12, pp. 1951-1957, 2003. (Pubitemid 38032126)
73. S. Nakae, A. Nambu, K. Sudo, and Y. Iwakura, "Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice," Journal of Immunology, vol. 171, no. 11, pp. 6173-6177, 2003. (Pubitemid 37467240)
74. E. Lubberts, L. van den Bersselaar, B. Oppers-Walgreen, et al., "IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-κB ligand/osteoprotegerin balance1," Journal of Immunology, vol. 170, no. 5, pp. 2655-2662, 2003. (Pubitemid 36245658)
75. T. Yago, Y. Nanke, M. Kawamoto, et al., "IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats," Arthritis Research and Therapy, vol. 9, no. 5, article R96, 2007.
76. E. Lubberts, M. Koenders, and W. B. van den Berg, "The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models," Arthritis Research and Therapy, vol. 7, no. 1, pp. 29-37, 2005. (Pubitemid 40214525)
77. S. Kotake, N. Udagawa, N. Takahashi, et al., "IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis," Journal of Clinical Investigation, vol. 103, no. 9, pp. 1345-1352, 1999. (Pubitemid 29218305)
78. I. B. McInnes, B. P. Leung, M. Harnett, J. A. Gracie, F. Y. Liew, and W. Harnett, "A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62," Journal of Immunology, vol. 171, no. 4, pp. 2127-2133, 2003. (Pubitemid 36966497)
79. S. L. Atkin, M. Kamel, A. M. A. El-Hady, S. A. El-Badawy, A. El-Ghobary, and W. C. Dick, "Schistosomiasis and inflammatory polyarthritis: a clinical, radiological and laboratory study of 96 patients infected by S. mansoni with particular reference to the diarthrodial joint," Quarterly Journal of Medicine, vol. 59, no. 229, pp. 479-487, 1986. (Pubitemid 16053369)
80. H. I. Ismail, F. A. Sallam, and H. A. Sheer, "The pathogenesis of arthropathy in experimental Schistosomiasis mansoni," Journal of the Egyptian Society of Parasitology, vol. 30, no. 3, pp. 943-949, 2000.
81. A. Cooke, P. Tonks, F. M. Jones, et al., "Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice," Parasite Immunology, vol. 21, no. 4, pp. 169-176, 1999. (Pubitemid 29158763)
82. L. A. B. Joosten, M. M. A. Helsen, T. Saxne, F. A. J. van De Loo, D. Heinegard, and W. B. van den Berg, "IL-1αj6 blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation," Journal of Immunology, vol. 163, no. 9, pp. 5049-5055, 1999. (Pubitemid 29501273)
83. N. Takagi, M. Mihara, Y. Moriya, et al., "Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis," Arthritis & Rheumatism, vol. 41, no. 12, pp. 2117-2121, 1998. (Pubitemid 29009369)
84. A. Kavanaugh, "Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment-data from randomized clinical trials," Bulletin of the NYU Hospital for Joint Diseases, vol. 65, supplement 1, pp. S16-S20, 2007.
85. M. Tunyogi-Csapo, K. Kis-Toth, M. Radacs, et al., "Cytokine- controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption," Arthritis & Rheumatism, vol. 58, no. 8, pp. 2397-2408, 2008.
86. E. Romas, M. T. Gillespie, and T. J. Martin, "Involvement of receptor activator of NFkB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis," Bone, vol. 30, no. 2, pp. 340-346, 2002. (Pubitemid 34154863)
87. E. Lubberts, B. Oppers-Walgreen, A. R. Pettit, et al., "Increase in expression of receptor activator of nuclear factor kB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis," Arthritis & Rheumatism, vol. 46, no. 11, pp. 3055-3064, 2002. (Pubitemid 35315901)
88. E. Romas, O. Bakharevski, D. K. Hards, et al., "Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis," Arthritis & Rheumatism, vol. 43, no. 4, pp. 821-826, 2000.
89. A. Reddy and B. Fried, "An update on the use of helminths to treat Crohn's and other autoimmunune diseases," Parasitology Research, vol. 104, no. 2, pp. 217-221, 2009.
90. R. W. Summers, D. E. Elliot, J. F. Urban Jr., R. Thompson, and J. V. Weinstock, "Trichuris suis therapy in Crohn's disease," Gut, vol. 54, no. 1, pp. 87-90, 2005. (Pubitemid 40007223)
91. R. W. Summers, D. E. Elliott, J. F. Urban Jr., R. A. Thompson, and J. V. Weinstock, "Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial," Gastroenterology, vol. 128, no. 4, pp. 825-832, 2005. (Pubitemid 40523535)
92. K. Mortimer, A. Brown, J. Feary, et al., "Dose-ranging study for trials of therapeutic infection with Necator americanus in humans," American Journal of Tropical Medicine and Hygiene, vol. 75, no. 5, pp. 914-920, 2006. (Pubitemid 351627540)
93. +) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars," Journal of Immunology, vol. 158, no. I, pp. 338-344, 1997. (Pubitemid 127483874)
94. O. Atochina, A. A. Da'dara, M. Walker, and D. A. Harn, "The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo," Immunology, vol. 125, no. 1, pp. 111-121, 2008.
95. P. Smith, R. E. Fallon, N. E. Mangan, et al., "Schistosoma mansoni secretes a chemokine binding protein with antiin-flammatory activity," Journal of Experimental Medicine, vol. 202, no. 10, pp. 1319-1325, 2005. (Pubitemid 41668734)
96. T. Kumagai, Y. Osada, N. Ohta, and T. Kanazawa, "Peroxiredoxin-1 from Schistosoma japonicum functions as a scavenger against hydrogen peroxide but not nitric oxide," Molecular and Biochemical Parasitology, vol. 164, no. 1, pp. 26-31, 2009.
97. S. Donnelly, C. M. Stack, S. M. O'Neill, A. A. Sayed, D. L. Williams, and J. P. Dalton, "Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages," FASEB Journal, vol. 22, no. II, pp. 4022-4032, 2008.
98. G. Schramm, F. H. Falcone, A. Gronow, et al., "Molecular characterization of an interleukin-4-inducing factor from Schistosoma mansoni eggs," Journal of Biological Chemistry, vol. 278, no. 20, pp. 18384-18392, 2003. (Pubitemid 36799460)
99. Y. Kina, S. Fukumoto, K. Miura, et al., "A glycoprotein from Spirometra erinaceieuropaei plerocercoids suppresses osteo-clastogenesis and proinflammatory cytokine gene expression," International Journal for Parasitology, vol. 35, no. 13, pp. 1399-1406, 2005. (Pubitemid 41484153)
100. N. Acevedo, J. Sánchez, A. Erler, et al., "IgE cross-reactivity between Ascaris and domestic mite allergens: the role of tropomyosin and the nematode polyprotein ABA-1," Allergy, vol. 64, no. 11, pp. 1635-1643, 2009.
101. J. J. Reece, M. C. Siracusa, T. L. Southard, C. F. Brayton, J. F. Urban Jr., and A. L. Scott, "Hookworm-induced persistent changes to the immunological environment of the lung," Infection and Immunity, vol. 76, no. 8, pp. 3511-3524, 2008.
102. F. Annunziato, L. Cosmi, F. Liotta, E. Maggi, and S. Romag-nani, "Type 17 T helper cells-origins, features and possible roles in rheumatic disease," Nature Reviews Rheumatology, vol. 5, no. 6, pp. 325-331, 2009.
103. S. Babu, S. Q. Bhat, N. P. Kumar, et al., "Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1," Journal of Infectious Diseases, vol. 200, no. 2, pp. 288-298, 2009.
104. Y. Yang, J. Weiner, Y. Liu, et al., "T-bet is essential for encephalitogenicity of both Th1 and Th17 cells," Journal of Experimental Medicine, vol. 206, no. 7, pp. 1549-1564, 2009.